|
FY2016
12 months to Sep 30, 2016
|
FY2015
12 months to Sep 30, 2015
|
FY2014
12 months to Sep 30, 2014
|
FY2013
12 months to Sep 30, 2013
|
FY2012
12 months to Sep 30, 2012
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Depreciation | |||||
| Amortization of debt discount | |||||
| Amortization of deferred loan fees | |||||
| Expense from financing costs paid in equity and debt issuance | |||||
| Stock-based compensation expense from options, warrants, and shares issued for services | |||||
| Bad debt allowance | |||||
| Expense paid with issuance of promissory note | |||||
| Gain on extinguishment of liabilities, net | |||||
| Non-cash charitable donations of fixed assets and stock | |||||
| Gain on disposal of equipment | |||||
| Other | |||||
| Changes in operating assets and liabilities | |||||
| Prepaid expenses and other current assets | |||||
| Accounts payable | |||||
| Accrued compensation and related expense | |||||
| Accrued interest and other liabilities | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities: | |||||
| Proceeds from sale of equipment | |||||
| Purchase of fixed assets | |||||
| Change in restricted cash | |||||
| Collection of notes receivable | |||||
| Collection of note receivable | |||||
| Net cash provided by investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from sale of common stock | |||||
| Proceeds from notes payable, net | |||||
| Financing Fees deducted from notes payable proceeds | |||||
| Proceeds from sale of preferred stock | |||||
| Proceeds from warrant exercise | |||||
| Principal payments on notes payable | |||||
| Net cash provided by financing activities | |||||
| Net change in cash and cash equivalents | |||||
| Cash and cash equivalents, beginning of period | |||||
| Cash and cash equivalents, end of period | |||||
| Supplemental cash flow information | |||||
| Cash paid for interest | |||||
| Noncash investing and financing activities | |||||
| Shares and warrants issued in connection with settlement of liabilities and conversion of convertible notes | |||||
| Settlement Of Liabilities And Conversion Of Convertible Notes | |||||
| Total shares and warrants issued in connection with settlement of liabilities and conversion of convertible notes | |||||
| Shares issued in connection with an asset purchase agreement | |||||
| Asset Purchase Agreement | |||||
| Discount (including beneficial conversion feature) on notes payable | |||||
| Warrants issued as a loan fee | |||||
| Original issue discount on notes payable issued | |||||
| Conversion of Series B and C preferred stock to common stock | |||||
| Accounts payable converted to debt | |||||
Loading...